DFDA

Clinical Trials for Type 2 Diabetes

Focusing on: SGLT2 Inhibitors

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Specify a medical condition you are interested in.

Specify a drug, device, or procedure if you are looking for trials for a specific intervention.

Displaying 10 of 218 results.

Page 1 of 22
SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers
Active, Not Recruiting
Interventions:SGLT2 inhibitor
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 80
Age: From 18 Years
Gender: ALL
Locations: University Hospital of Patras
View Study Details
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Recruiting
Interventions:SGLT2 inhibitor
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 1000
Age: From 19 Years
Gender: ALL
Locations: Seoul St. Mary's Hospital
Join Study
SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
Active, Not Recruiting
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 200000
Age: From 19 Years
Gender: ALL
Locations: Yongin Severance Hospital, Yonsei University Health System
View Study Details
The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus
Enrolling by Invitation
Interventions:SGLT2 inhibitor
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 716
Age: 20 Years - 80 Years
Gender: ALL
Locations: Ewha womans university mokdong hospital
View Study Details
SGLT-2 Inhibitors in the Treatment of Ascites
Recruiting
Interventions:SGLT2 inhibitor
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 40
Age: 18 Years - 80 Years
Gender: ALL
Locations: Internal Medicine Unit, V. Cervello Hospital; Department of Internal Medicine, University Hospital of Palermo
Join Study
Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
Completed
Conditions:Type 2 Diabetes
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 10000
Age: 18 Years - 90 Years
Gender: ALL
Locations: Division of Metabolic Diseases, University Hospital of Padova
View Study Details
Performance Under SGLT-2-Inhibitors in Humans
Completed
Interventions:N/A
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 450
Age: From 40 Years
Gender: ALL
Locations: Berner Klinik Montana
View Study Details
Effects of Diabetes Medications on Adrenal Function and Intestinal Microbiota
Completed
Conditions:Type 2 Diabetes
Study Type: OBSERVATIONAL
Phase: N/A
Enrollment: 23
Age: From 18 Years
Gender: ALL
Locations: Tartu University Hospital
View Study Details
Impact of SGLT2 on Glucosuria in HNF1A-MODY
Completed
Study Type: INTERVENTIONAL
Phase: NA
Enrollment: 21
Age: From 18 Years
Gender: ALL
Locations: Steno Diabetes Center Copenhagen
View Study Details
Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin
UnknownLast Known: NOT_YET_RECRUITING
Conditions:Type2 Diabetes
Interventions:SGLT2 inhibitor
Study Type: INTERVENTIONAL
Phase: PHASE4
Enrollment: 100
Age: N/A
Gender: ALL
Locations: N/A
View Study Details